No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BLFS240517C22500
- 0.10
- -0.20-66.67%
15min DelayClose May 10 15:55 ET
0.10High0.10Low
0.10Open0.30Pre Close5 Volume2 Open Interest22.50Strike Price50.00Turnover181.19%IV18.86%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type0.2982Delta0.0809Gamma26.95Leverage Ratio-0.1436Theta0.0007Rho8.04Eff Leverage0.0082Vega
Intraday
- 5D
- 1D
News
Several BioLife Solutions Insiders Sell Shares Sending Potential Negative Signal
BioLife Solutions, Inc. (NASDAQ:BLFS) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When evaluating insider transactions, knowing whether in
BioLife Solutions | 10-Q: Quarterly report
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
Comments
BioLife Solutions, despite more cash than debt, is seen as risky due to lack of profitability and negative cash flow. The company's future financial health hinges on its earnings.
Is BioLife Solutions (NASDAQ:BLFS) Using Too Much Debt? 1
The stock's low price indicates a potential buying opportunity. However, its high beta suggests volatility. The company's optimistic future outlook isn't fully reflected in the current share price.
BioLife Solutions' worrying forecast of increased losses and reduced revenues could wane investor confidence. The company's long-term business trajectory is vital for creating shareholder value.
Lack of insider transactions might be discouraging for the company's share outlook and the stated insider ownership is not really impressive.
Core points:
1. There are three platforms: first, cell processing, which includes biopreservation media and Sexton cell processing products; second is our freezers and thaw systems platform comprised of cryogenic liquid nitrogen freezers and Sterling ULT mechanical freezers and automated thawing Instruments; and finally, storage and storage services, which includes our SciSafe storage services and our evo col...
1. There are three platforms: first, cell processing, which includes biopreservation media and Sexton cell processing products; second is our freezers and thaw systems platform comprised of cryogenic liquid nitrogen freezers and Sterling ULT mechanical freezers and automated thawing Instruments; and finally, storage and storage services, which includes our SciSafe storage services and our evo col...
Read more